BAQSIMI™ Glucagon 3 mg Powder

BAQSIMI, PDR NASAL SPR 3MG

BAQSIMI® is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above
Nasal powder: intranasal device containing one dose of glucagon 3 mg
Dry nasal powder form of glucagon
More …

McKesson Item #1253681

BAQSIMI™ Glucagon 3 mg Powder

Email To You may enter multiple email addresses separated by semicolons.

Email From

Message

Characters Left: 255

Send

View Alternatives

McKesson #

1253681

Manufacturer #

00548835101

Brand

BAQSIMI™

Manufacturer

Amphastar Pharma

Country of Origin

Unknown

Alternate Manufacturer Number

2920023

Application

Glycogenolytic Agent

Container Type

Nasal Spray Device

Dosage Form

Powder

Generic Drug Code

46726

Generic Drug Name

Glucagon

NDC Number

00548835101

Strength

3 mg

UNSPSC Code

51183602

BAQSIMI® is indicated for the treatment of severe hypoglycemia in adult and pediatric patients with diabetes ages 4 years and above
Nasal powder: intranasal device containing one dose of glucagon 3 mg
Dry nasal powder form of glucagon
One Count